Araştırma Makalesi

Effects of Ascorbic Acid and Sodium Selenite on Inflammatory Response and Apoptosis in Renal Ischemia-Reperfusion Injury

Cilt: 7 Sayı: 1 1 Mart 2022
PDF İndir
TR EN

Effects of Ascorbic Acid and Sodium Selenite on Inflammatory Response and Apoptosis in Renal Ischemia-Reperfusion Injury

Abstract

Objective: The aim of this study is to investigate the anti-inflammatory and anti-apoptotic effects of ascorbic acid (AA) and sodium selenite (SS) administration in renal ischemia and reperfusion (IR) injury.
Materials and Methods: Twenty-eight Wistar-albino rats were divided into four groups. Group I; Control group, Group II; IR group, Group III; IR+0.25mg/kg SS and 100mg/kg AA and Group IV; IR+0.50mg/kg SS and 200mg/kg AA. In the control group, only surgical stress was created. In the IR group, 60 minutes of ischemia and 24 hours of reperfusion were applied in the left kidney after right nephrectomy. SS and AA were administered to Groups III and IV at doses determined 5 days before the IR procedure.
Results: In comparison of Group II with Group I, Group III and Group IV; severe damage was observed in the morphological structures of the glomerulus and renal tubules in Group II (p<0.05). Compared to Group I, Group III and Group IV the expression of TNF-α, IL-6, Caspase-3, and Bcl-2 and the percentage of positive cells increased statistically in Group II (p<0.001).
Conclusion: This study determined that prophylactic administration of ascorbic acid and sodium selenite showed protective effects against acute kidney injury. 

Keywords

Kaynakça

  1. Cheng Z, Guo C. Pemafibrate pretreatment attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by modulating jak2/stat3β/pparα pathway. PPAR Research. 2021;2021:1-15. doi:10.1155/2021/6632137
  2. Yamaguchi M, Okamoto K, Kusano T, et al. The effects of xanthine oxidoreductase inhibitors on oxidative stress markers following global brain ischemia reperfusion injury in C57BL/6 mice. PLoS One. 2015;10(7):e0133980. doi:10.1371/journal. pone.0133980
  3. Basile DP, Yoder MC. Renal endothelial dysfunction in acute kidney ischemia reperfusion injury. Cardiovascular & Haematological Disorders-Drug Targets. 2014; 14(1):3-14.
  4. Bhogal RH, Sutaria R, Afford SC. Hepatic liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transpl. 2011;17:95. doi:10.1002/lt.22205
  5. Ma M, Ma ZH. Effect of tumor necrosis factor-alpha in rats with hepatic ischemia-reperfusion injury. Hepatobiliary&Pancreatic Diseases International. 2008;7:296-299.
  6. Dai J, Chen Q, Huang W, et al. Liver kinase B1 attenuates liver ischemia/reperfusion injury via inhibiting the NLRP3 inflammasome. Acta Biochimica et Biophysica Sinica. 2021;53:601-611.
  7. Kezić A, Stajic N, Thaiss F. Innate immune response in kidney ischemia/reperfusion injury: potential target for therapy. Journal of immunology research. 2017;2017:1-10. doi:10.1155/2017/6305439
  8. Pefanis A, Ierino FL, Murphy JM, Cowan PJ. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney international. 2019;96:291-301. doi:10.1016/j.kint.2019.02.009

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

1 Mart 2022

Gönderilme Tarihi

11 Ocak 2022

Kabul Tarihi

21 Ocak 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 7 Sayı: 1

Kaynak Göster

AMA
1.Doğanay S, Budak Ö. Effects of Ascorbic Acid and Sodium Selenite on Inflammatory Response and Apoptosis in Renal Ischemia-Reperfusion Injury. OTSBD. 2022;7(1):130-136. doi:10.26453/otjhs.1056107

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya lisans verenin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.